A RANDOMIZED TRIAL OF MELPHALAN AND PREDNISONE VERSUS MELPHALAN, PREDNISONE, CYCLOPHOSPHAMIDE, MECCNU, AND VINCRISTINE IN UNTREATED MULTIPLE-MYELOMA

被引：31
|
作者：
PAVLOVSKY, S [1 ]
SASLAVSKY, J [1 ]
PINTO, MT [1 ]
PALMER, L [1 ]
CURUCHET, M [1 ]
LEIN, JM [1 ]
GARAY, G [1 ]
DRAGOSKY, M [1 ]
QUIROGAMICHEO, E [1 ]
HUBERMAN, AB [1 ]
PIZZOLATTO, M [1 ]
机构：
[1] GRP ARGENTINO TRATAMIENTO LEUCEMIA AGUDA,BUENOS AIRES,ARGENTINA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1984年 / 2卷 / 07期
关键词：
D O I：
10.1200/JCO.1984.2.7.836
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：836 / 840
页数：5
相关论文
共 50 条
  • [1] PEPTICHEMIO, VINCRISTINE AND PREDNISONE VERSUS MELPHALAN AND PREDNISONE AS INDUCTION THERAPY IN MULTIPLE-MYELOMA
    RICCARDI, A
    MERLINI, G
    MONTECUCCO, C
    DANOVA, M
    UCCI, G
    CASSANO, E
    ASCARI, E
    [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (07): : 787 - 791
  • [2] ASSESSMENT OF MELPHALAN AND PREDNISONE (MP) VERSUS THE SAME DRUGS PLUS CYCLOPHOSPHAMIDE, MECCNU AND VINCRISTINE (MPCCV) IN THE TREATMENT OF MULTIPLE-MYELOMA
    PAVLOVSKY, S
    SASLAVSKY, J
    PINTO, MT
    CAVAGNARO, F
    CURUTCHET, M
    LEIN, JM
    GARAY, G
    DRAGOSKY, M
    BERGNA, L
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 536 - 536
  • [3] Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma
    Zweegman, Sonja
    van der Holt, Bronno
    Mellqvist, Ulf-Henrik
    Salomo, Morten
    Bos, Gerard M. J.
    Levin, Mark-David
    Visser-Wisselaar, Heleen
    Hansson, Markus
    van der Velden, Annette W. G.
    Deenik, Wendy
    Gruber, Astrid
    Coenen, Juleon L. L. M.
    Plesner, Torben
    Klein, Saskia K.
    Tanis, Bea C.
    Szatkowski, Damian L.
    Brouwer, Rolf E.
    Westerman, Matthijs
    Leys, M. B. L.
    Sinnige, Harm A. M.
    Haukas, Einar
    van der Hem, Klaas G.
    Durian, Marc F.
    Mattijssen, E. J. M.
    van de Donk, Niels W. C. J.
    Stevens-Kroef, Marian J. P. L.
    Sonneveld, Pieter
    Waage, Anders
    [J]. BLOOD, 2016, 127 (09) : 1109 - 1116
  • [4] INTERFERON-ALPHA-2A MELPHALAN PREDNISONE VERSUS MELPHALAN PREDNISONE IN PREVIOUSLY UNTREATED PATIENTS WITH MULTIPLE-MYELOMA
    MONTUORO, A
    DEROSA, L
    DEBLASIO, A
    PACILLI, L
    PETTI, N
    DELAURENZI, A
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1990, 76 (03) : 365 - 368
  • [5] Prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosis
    Gertz, MA
    Lacy, MQ
    Lust, JA
    Greipp, PR
    Witzig, TE
    Kyle, RA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) : 262 - 267
  • [6] A prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosis
    Gertz, MA
    Lacy, MQ
    Lust, JA
    Greipp, PR
    Witzig, TE
    Kyle, RA
    [J]. AMYLOID AND AMYLOIDOSIS 1998, 1999, : 96 - 98
  • [7] EFFECTIVENESS OF 2-STAGE TREATMENT OF MULTIPLE-MYELOMA WITH MELPHALAN AND WITH MELPHALAN IN COMBINATION WITH CYCLOPHOSPHAMIDE, CARMUSTINE, VINCRISTINE AND PREDNISONE
    SNIGUROWICZ, J
    KRAJ, M
    ROSTKOWSKA, J
    MAJ, S
    MARIANSKA, B
    MENDEK, E
    ROSZKOWSKI, S
    KILIAN, Z
    KOLAKOWSKI, L
    [J]. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 1981, 29 (02) : 145 - 153
  • [8] A RANDOMIZED TRIAL OF MAINTENANCE VERSUS NO MAINTENANCE MELPHALAN AND PREDNISONE IN RESPONDING MULTIPLE-MYELOMA PATIENTS
    BELCH, A
    SHELLEY, W
    BERGSAGEL, D
    WILSON, K
    KLIMO, P
    WHITE, D
    WILLAN, A
    [J]. BRITISH JOURNAL OF CANCER, 1988, 57 (01) : 94 - 99
  • [9] MULTIPLE-MYELOMA RESISTANT TO MELPHALAN - TREATMENT WITH CYCLOPHOSPHAMIDE, PREDNISONE, AND BCNU
    KYLE, RA
    GAILANI, S
    SELIGMAN, BR
    BLOM, J
    MCINTYRE, OR
    PAJAK, TF
    HOLLAND, JF
    [J]. CANCER TREATMENT REPORTS, 1979, 63 (08): : 1265 - 1269
  • [10] A prospective randomized trial of melphalan and prednisone versus vincristine Carmustine (BCNU), melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosis.
    Gertz, MA
    Lacy, MQ
    Lust, JA
    Greipp, PR
    Witzig, TE
    Kyle, RA
    [J]. BLOOD, 1998, 92 (10) : 318A - 319A
12345